SII CEO Adar Poonawalla said on Saturday that its partnership for a
Covid-19 vaccine with Novavax has shown excellent efficacy results.
"We have applied for starting trials in India. Hope to launch Covocax
by June 2021," Poonawalla said in a tweet. The new vaccine shall be
launched under the brand name of Covovax, which SII is manufacturing
in partnership with Novovax. The Pune-based global vaccine giant has
sought permission from the DCGI to start domestic trials of the new
product.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/serum-institute-of-india-plans-to-launch-covovax-by-june-adar-poonawalla/articleshow/80603049.cms
No comments:
Post a Comment